Here, we attempted to identify a genetic/epigenetic/immunological CRC signature by investigating CRC samples from the TCGA database that harbor at least two or three deregulations of CIITA, HDAC2, and B2M genes. This evidence concerns the gene B2M and colorectal carcinoma.